Niaspan and atrial fibrillation Patient Reports February 11, 2012

Niaspan Side Effects Report #5947214-7
Niaspan side effect was reported by a Health Professional from NETHERLANDS on Nov 10, 2008. Male patient, weighting 194.0 lb, was diagnosed with lipoprotein (a) increased, blood cholesterol increased, haemodilution and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery occlusion, hot flush. Niaspan dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE CALCIUM, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #6004673-1
Niaspan side effect was reported by a Health Professional from NETHERLANDS on Dec 08, 2008. Male patient, weighting 194.0 lb, was diagnosed with lipoprotein (a) increased, blood cholesterol increased, haemodilution and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery occlusion, hot flush. Niaspan dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE CALCIUM, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #6012613-4
Niaspan side effect was reported by a Health Professional from NETHERLANDS on Dec 18, 2008. Male patient, weighting 194.0 lb, was diagnosed with lipoprotein (a) increased, blood cholesterol increased, haemodilution and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery occlusion, hot flush. Niaspan dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE CALCIUM, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5944067-8
Niaspan side effect was reported by a Health Professional from NETHERLANDS on Oct 29, 2008. Male patient, weighting 194.0 lb, was diagnosed with lipoprotein (a) abnormal, blood cholesterol increased, haemodilution and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , coronary artery occlusion, hot flush. Niaspan dosage: unknown. During the same period patient was treated with ACETYLSALICYLATE CALCIUM, SIMVASTATIN. Patient was hospitalized. Patient recovered.


Niaspan Side Effects Report #5860640-X
Niaspan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Male patient, weighting 155.1 lb, was diagnosed with high density lipoprotein decreased, blood cholesterol increased, cardiovascular event prophylaxis, atrial fibrillation  and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , glucose tolerance impaired. Niaspan dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, CLOPIDOGREL, ATENOLOL, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5860906-3
Niaspan side effect was reported by a Physician from UNITED STATES on May 12, 2008. Male patient, weighting 220.2 lb, was diagnosed with high density lipoprotein decreased, low density lipoprotein increased, convulsion and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , burning sensation, flushing, heart rate irregular, tachycardia. Niaspan dosage: unknown. During the same period patient was treated with PHENOBARBITAL, RANITIDINE. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5927341-0
Niaspan side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2008. Male patient, weighting 167.2 lb, was diagnosed with high density lipoprotein decreased, blood cholesterol increased, hypertension and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , balance disorder, bone erosion, cerebrovascular accident, contusion, coronary artery occlusion, discomfort, hallucination, headache . Niaspan dosage: unknown. During the same period patient was treated with VERAPAMIL, ASPIRIN, DIOVAN HCT, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #6124540-2
Niaspan side effect was reported by a Physician from UNITED STATES on Mar 12, 2009. Male patient, weighting 194.2 lb, was diagnosed with high density lipoprotein decreased, low density lipoprotein increased, nasopharyngitis, cardiac disorder, pharyngeal disorder, flatulence, hypersensitivity and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , haematemesis, haematochezia, heart rate increased, nasopharyngitis, protein total abnormal, red blood cell abnormality. Niaspan dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, NEXIUM, NASONEX. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5861056-2
Niaspan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2008. Male patient, weighting 220.5 lb, was diagnosed with blood cholesterol increased, gastrooesophageal reflux disease, hypertension and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , dizziness , flushing. Niaspan dosage: unknown. During the same period patient was treated with DIGOXIN, OMEPRAZOLE, METOPROLOL TARTRATE, PROPAFENONE. Patient was hospitalized. Patient recovered.


Niaspan Side Effects Report #5861616-9
Niaspan side effect was reported by a Consumer or non-health professional from UNITED STATES on June 02, 2008. Male patient, weighting 205.2 lb, was diagnosed with blood cholesterol increased, prostatomegaly, hypertension and was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , flushing. Niaspan dosage: unknown. During the same period patient was treated with HYTRIN, AVADART, METOPROLOL TARTRATE, VALSARTAN, TERAZOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5061194-0
Niaspan side effect was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient, 63 years of age, weighting 189.0 lb, was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , flushing, syncope. Niaspan dosage: 500MG DAILY PO. During the same period patient was treated with AMLODIPINE, ZETIA, LISINOPRIL, METOPROLOL SUCCINATE EXTENDED RELEASE, SIMVASTATIN, NITROGLYCERIN, WARFARIN. Patient recovered.

Niaspan Side Effects Report #5332831-8
Niaspan side effect was reported by a Health Professional from SWITZERLAND on May 10, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , blood alkaline phosphatase increased, duodenal ulcer haemorrhage, gamma-glutamyltransferase increased, hot flush, liver disorder. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5378627-2
Niaspan side effect was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , blood alkaline phosphatase increased, duodenal ulcer haemorrhage, flushing, gamma-glutamyltransferase increased, liver disorder. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5392836-8
Niaspan side effect was reported by a Health Professional from SWITZERLAND on July 04, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , duodenal ulcer haemorrhage, hepatic neoplasm, hepatocellular damage. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.


Niaspan Side Effects Report #5400005-8
Niaspan side effect was reported by a Health Professional from SWITZERLAND on July 12, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , duodenal ulcer haemorrhage, focal nodular hyperplasia, hepatocellular damage. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5404289-1
Niaspan side effect was reported by a Health Professional from SWITZERLAND on July 17, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: atrial fibrillation , cholestasis, duodenal ulcer haemorrhage, hepatic cirrhosis, hepatocellular damage, liver disorder. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN, METO ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.

Niaspan Side Effects Report #5410330-2
Niaspan side effect was reported by a Health Professional from SWITZERLAND on July 26, 2007. Male patient, 57 years of age, was treated with Niaspan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , blood alkaline phosphatase increased, cholestasis, duodenal ulcer haemorrhage, flushing, gamma-glutamyltransferase increased, hepatic cirrhosis. Niaspan dosage: 500 MG QD PO. During the same period patient was treated with MARCUMAR, ASPIRIN CARDIO, BELOC ZEROK, INEGY, IRBESARTAN, AMIODARON, NEXIUM. Patient was hospitalized. Patient recovered.